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Abstract
This study represents the first report on the development of a novel spectrophotometric method for determination
of cinacalcet hydrochloride (CIN) in its tablet dosage forms. Studies were carried out to investigate the reaction
between CIN and 1,2-naphthoquinone-4-sulphonate (NQS) reagent. In alkaline medium (pH 8.5), an orange red-
colored product exhibiting maximum absorption peak (lmax) at 490 nm was produced. The stoichiometry and
kinetic of the reaction were investigated and the reaction mechanism was postulated. This color-developing
reaction was employed in the development of a simple and rapid visible-spectrophotometric method for
determination of CIN in its tablets. Under the optimized reaction conditions, Beer’s law correlating the absorbance
with CIN concentration was obeyed in the range of 3 - 100 μg/ml with good correlation coefficient (0.9993). The
molar absorptivity (ε) was 4.2 × 105 l/mol/cm. The limits of detection and quantification were 1.9 and 5.7 μg/ml,
respectively. The precision of the method was satisfactory; the values of relative standard deviations (RSD) did not
exceed 2%. No interference was observed from the excipients that are present in the tablets. The proposed
method was applied successfully for the determination of CIN in its pharmaceutical tablets with good accuracy
and precisions; the label claim percentage was 100.80 - 102.23 ± 1.27 - 1.62%. The results were compared favorably
with those of a reference pre-validated method. The method is practical and valuable in terms of its routine
application in quality control laboratories.
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Background
Cinacalcet hydrochloride (CIN); N-[1-(R)-(-)-(1-naphthyl)
ethyl]-3-[3-(trifluoromethyl) phenyl]-1-aminopropane HCl
is a selective calcimimetic agent, which acts on a calcium-
sensing receptor of the parathyroid gland. This principal
negative regulator of parathyroid hormone release
increases its selectivity to activation by extracellular cal-
cium, thus decreasing the parathyroid hormone levels
[1,2]. CIN is effective in clinical setting and it has been
approved for the treatment of secondary hyperthyroidism
in patients with chronic kidney disease placed on dialysis
[3], and for the treatment of elevated calcium levels in
patients with parathyroid carcinoma [4].
The effective and safe therapy with CIN is basically
depending on the quality of its pharmaceutical prepara-
tions (tablets), and assessing its concentrations in tablets
for the purposes of quality control. Literature review
revealed that there were only two methods were
employed for thin-layer [5] and liquid chromatographic
[5,6] enantiomeric separation of CIN enantiomers in
laboratory-made racemic mixtures. However, no reports
have been found for describing the development of ana-
lytical methods for the quantitative determination of
CIN in its tablets. Therefore, this study was devoted to
the development of a new method for determination of
CIN in its tablets for the purpose of its pharmaceutical
quality control.
Spectrophotometry is considered the most convenient
technique because of its inherent simplicity, low cost
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and wide availability [7]. As well, 1,2-Naphthoquinone-
4-sulphonic sulphonate (NQS) has been used as a color-
developing reagent in the spectrophotometric determi-
nation of many pharmaceutical amines [8-11]. The reac-
tion between NQS and CIN has not been investigated
yet. Therefore, the present study was devoted to investi-
gate this and its employment in the development of a
new simple and rapid spectrophotometric method for
determination of CIN in its tablets.
Experimental
Apparatus
Double beam V-530 (JASCO Ltd., Kyoto, Japan) ultra-
violet-visible spectrophotometer with matched 1-cm
quartz cells was used for all the spectrophotometric
measurements. pH meter, model 350 (Bibby Scientific
Ltd., T/As Jenway, Essex, England). MLW type thermo-
statically controlled water bath (Memmert GmbH Co.,
Schwabach, Germany).
Reagents and Materials
Cinacalcet hydrochloride (Amgen Inc., Thousand Oaks,
CA, USA) was obtained and used as received; its purity
was > 99%. A solution of 0.5% (w/v) of NQS (Aldrich
Chemical Co., St. Louis, USA) was freshly prepared and
protected from light during use. Clark and Lubs buffer
solution was prepared by mixing 50 ml of 0.2 M aqu-
eous solution of boric acid and potassium chloride (1
liter containing 12.368 g of boric acid and 14.90 g of
potassium chloride) with 21.3 ml of 0.2 M sodium
hydroxide in 200 ml standard flask [12], and adjusted by
pH meter. Tris buffer was prepared by mixing 100 ml
0.1 M tris(hydroxymethyl)aminomethane with 29.4 ml
of 0.1 M HCl [13]. Britton-Robinson buffer composed of
0.04 M boric acid, 0.04 M phosphoric acid and 0.04 M
acetic acid adjusted at pH 8.5 by using 0.2 M sodium
hydroxide [8]. Phosphate buffer composed of 0.1 M dis-
odium hydrogen phosphate (14.2 g/l) and 0.1 M sodium
hydroxide [13]. Sensipar® and Mimpara® tablets
(Amgen Inc, Thousand Oaks, CA, USA) were labeled to
contain 60 mg CIN per tablet. Double distilled water
was obtained through WSC-85 water purification system
(Hamilton Laboratory Glass Ltd., Kent, USA) and used
throughout the work. All solvents and materials used
throughout this study were of analytical grade.
Preparation of Solutions
Standard CIN Solution
An accurately weighed amount (50 mg) of CIN was
quantitatively transferred into a 25-ml calibrated flask,
dissolved in 20 ml distilled water, completed to volume
with the same solvent to obtain a stock solution of 2
mg/ml. The stock solution was found to be stable for at
least two weeks when kept in a refrigerator. The stock
solution was further diluted with water to obtain work-
ing solutions in the range of 3 - 100 μg/ml.
Tablet Sample Solution
Twenty tablets were weighed and finely powdered. An
accurately weighed quantity of the powder equivalent to
100 mg of the active ingredient was transferred into a
100-ml calibrated flask, and dissolved in about 40 ml of
distilled water. The contents of the flask were swirled,
sonicated for 5 minutes, and then completed to volume
with water. The contents were mixed well and filtered;
the first portion of the filtrate was rejected. The filtered
solution was diluted quantitatively with distilled water
to obtain suitable concentrations for the analysis by the
proposed spectrophotometric method.
General Recommended Procedures
One milliliter of CIN solution containing 3 - 100 μg/ml
was transferred into separate 10-ml calibrated flask. A
0.5 ml of tris buffer solution of pH 8.5 and 1 ml of
NQS solution (0.5%, w/v) were added. The reaction
solution was allowed to proceed for 10 min at room
temperature (25 ± 2°C) and completed to volume with
water. The resulting solution was measured at 490 nm
against reagent blank treated similarly.
Determination of Stoichiometric Ratio
Job’s Method
The Job’s method of continuous variation [14] was
employed. Master equimolar (1 × 10-4 M) aqueous solu-
tions of CIN and NQS were prepared. Series of 10-ml
portions of the master solutions of CIN and NQS were
made up comprising different complementary propor-
tions (0:10, 1:9,..., 9:1, 10:0, inclusive) in 10-ml calibrated
flasks containing 0.5 ml of tris buffer solution (pH 8.5).
The solutions were further manipulated as described
under the general recommended procedures.
Limiting Logarithmic Method
The limiting logarithmic method [15] was employed.
Two sets of experiments were carried out employing the
general recommended procedures described above. The
first set of experiments was carried using varying con-
centrations of the analytical reagent (1.9 × 10-3 - 9.6 ×
10-3 M) at a fixed CIN concentration (1 × 10-4 M). The
second set of experiments was carried using varying
concentrations of CIN (7.6 × 10-6 - 2.5 × 10-4 M) at a
fixed concentration of NQS (1.9 × 10-2 M). The loga-
rithms of the obtained absorbances for the reaction of
CIN with NQS were plotted as a function of the loga-
rithms of the concentrations of the reagent and CIN in
the first and second sets of experiments. The slopes of
the fitting lines in both sets of experiments were
calculated.
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Results and Discussion
Absorption Spectrum
The absorption spectrum of CIN was recorded against
water (Figure 1). It was found that CIN exhibits two
maximum absorption peaks (lmax) at 235 and 320 nm,
and the molar absorptivities (ε) at these wavelengths
were 5.1 × 104 and 1.7 × 104 l/ml/cm, respectively.
Because of the blue shifted lmax of CIN, its determina-
tion in the pharmaceutical formulations based on the
direct measurement of its absorption for ultraviolet light
is susceptible to potential interferences from the co-
extracted excipients. Therefore, derivatization of CIN to
a more red-shifted derivative was necessary. CIN con-
tains secondary amino group for which many chromo-
genic reagents are available for color-producing
reactions. These reactions include formation of colored
charge-transfer complex with electron acceptor [16], for-
mation of ion-pair associates with pairing reagents
[17-19], and formation of condensation product with a
chromogenic reagent [20]. These methods are usually
associated with some major drawbacks such as laborious
multiple extraction steps in the analysis by ion-pair
based methods [17-19], or in preparation of the free
base of the drug prior to the analysis by charge-transfer-
based methods [16], and long reaction time, thus the
procedure is time-consuming [20]. Darwish et al.
[21-24] has demonstrated that NQS is a valuable color-
developing reagent in the development of simple spec-
trophotometric methods for the determination of many
pharmaceutical amines in the form of their acid salts.
For these reasons, the present study was devoted to
investigate the reaction between NQS and CIN, and
employed this color reaction in the development of a
new simple and rapid spectrophotometric method for
determination of CIN in its tablets. The reaction
between CIN and NQS was performed, and the absorp-
tion spectrum of the reaction product was recorded
against reagent blank. The product was orange red-
colored exhibiting lmax at 490 nm (Figure 1). Obviously,
the lmax of CIN-NQS derivative was red-shifted from
the underivatized CIN by 171 nm. As well, the value of
ε (sensitivity) was greatly enhanced to be 4.2 × 105 l/
mol/cm. The following paragraphs describe the optimi-
zation of the reaction conditions.
Optimization of Reaction Conditions
Effect of NQS Concentration
Studying the effect of NQS concentration on its reaction
with CIN revealed that the reaction was dependent on
the NQS concentration as the readings increased with
the increase in the reagent concentration (Figure 2).
The highest readings were attained at a concentration
range of 0.4 - 0.6% (w/v) beyond which the readings
slightly decreased. A concentration of 0.5% (w/v) was
used in all the subsequent experiments.
Effect of pH and Buffer Components
The influence of pH on the reaction of CIN with NQS
was investigated by carrying out the reaction in buffer
solution of varying pH values. The results revealed that
CIN has difficulty to react with NQS in acidic media
(Figure 2). This was possibly due to the existence of the
amino group of CIN in the form of hydrochloride salt,
thus it loses its nucleophilic substitution affinity. As the
pH increased, the readings increased rapidly, as the
amino group of CIN (in the hydrochloride salt) turns
into the free amino group, thus facilitating the nucleo-
philic substitution. The maximum readings were
attained at pH values of 8.5. At higher pH, sharp
decrease in the readings occurred. This was attributed
Figure 1 Absorption spectra of CIN against water (1), NQS
against water (2), and their reaction product against reagent
blank (3).
Figure 2 Effect of NQS concentration (●) and pH (▲) on the
reaction of CIN (70 μg/ml) with NQS (0.5%, w/v).
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probably to the increase in the amount of hydroxide ion
that holds back the reaction of CIN with NQS, and the
instability of NQS reagent [25].
In order to investigate the effect of buffer components
on the reaction, different buffer solutions of pH 8.5
were tested: Clark, Robinson, phosphate, borate and tris
buffers. The highest absorbances were obtained when
tris buffer was used, thus it was used in all the subse-
quent experiments.
Effect of Temperature and Time
The effect of temperature on the reaction was studied
by carrying out the reaction at room temperature (25 ±
2°C) and at varying elevated temperatures (30 - 60°C).
The results (Figure 3) revealed that there was no signifi-
cant difference between the readings that have been
obtained at room temperature and those at elevated
temperatures up to 50°C, beyond which the readings sig-
nificantly decreased. In order to establish simple analyti-
cal procedures with no need for extra equipment (water
bath), further experiments were carried out at room
temperature.
In order to determine the optimum time that is
required for completion the reaction, it was allowed to
proceed at room temperature for varying periods of
time. It was found that the reaction goes to almost com-
pletion within 5 min (Figure 3), however for higher pre-
cision readings, the reaction was allowed to proceed for
quite longer time; reactions in all the subsequent experi-
ments were carried out for 10 min.
Effect of Diluting Solvent
Upon diluting the reaction solutions with water, trans-
parent solution was obtained indicating the solubility of
the CIN-NQS product in water, and the possibility of
using water as a diluting solvent. In order to select the
most appropriate solvent for diluting the reaction solu-
tions, different solvents were tested and compared with
water; these solvents were methanol, ethanol, isopropa-
nol, acetone, acetonitrile, and 1,4-dioxane. The highest
readings were obtained when ethanol was used for dilu-
tion (Figure 4). However, the use of organic solvents
leads to high analysis cost, and more importantly, the
incidence of exposure of the analysts to the side effects
of these toxic solvents [26-30]. Therefore, water was
used as a diluting solvent in the subsequent investiga-
tion on the expense of the higher sensitivity, which was
not a main concern in the present study as the method
was devoted to the analysis of CIN in its dosage forms
that does not require highly sensitive assay.
Stability of the Chromogen
The effect of time on the stability of the CIN-NQS
chromogen was studied by following the absorption
intensity of the reaction solution (after dilution) at dif-
ferent time intervals. It was found that the absorbance
of the chromogen remains stable for at least 1 h. This
allowed the processing of large batches of samples, and
their comfortable measurements with convenience. This
gives the high throughput property to the proposed
method when applied for analysis of large number of
samples in quality control laboratories.
Stoichiometry, Kinetics and Mechanism of the Reactions
Under the optimum conditions (Table 1), the stoichio-
metry of the reaction between CIN and NQS was inves-
tigated by Job’s [14] and limiting logarithmic [15]
methods. The symmetrical bell shape of Job’s plot (not
shown data) indicated that the CIN:NQS ratio was 1:1.
Figure 3 Effect of temperature (▲) and time (●) on the reaction
of CIN (70 μg/ml) with NQS (0.5%, w/v).
Figure 4 Effect of diluting solvent on the absorbances of the
reaction product between CIN (70 μg/ml) with NQS (0.5%, w/
v). Abbreviated olvents are: methanol (MeOH), ethanol (EtOH),
isopropanol (ISP), acetone (ACN), acetonitrile (MeCN), and 1,4-
dioxane (DIX).
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In the limiting logarithmic method, two straight lines
were obtained (Figure 5). The slopes of these lines were
1.0109 and 1.0565, confirming the 1:1 ratio for the reac-
tion. Based on this ratio, the reaction pathway was pos-
tulated to be proceeded as shown in Figure 6.
Under the optimum conditions, the signal-time curves
for the reactions at varying concentrations of CIN (1.27
× 10-4 - 2 × 10-4 M) for the reaction with a fixed con-
centration of NQS (1.92×10-3 M) were generated. The
initial reaction rates (K) were determined from the
slopes of these curves. The logarithms of the reaction
rates (log K) were plotted as a function of logarithms of
CIN concentrations (log C). A straight line with slope
value of 1.0519 was obtained (Figure 7), by fitting the
data to the following equation:
logK = logK ′ + n logC
where K is reaction rate, K’ is the rate constant, C is
the molar concentration of CIN and n (slope of
regression line) is the order of the reaction. The values
of the slope (≈1) confirmed that the reaction was first
order. However under the optimized reaction condi-
tions, the concentrations of NQS were in much more
excess than that of CIN in the reaction solution. There-
fore, the reaction was regarded as pseudo-first order
reaction.
Validation of the Proposed Method
Calibration and Sensitivity
Under the optimum reaction conditions (Table 1), the
calibration curve for the determination of CIN by its
reaction with NQS was constructed by plotting the
absorbances as a function of the corresponding concen-
trations. The regression equation for the results was A
= 0.0092 + 0.0090 C (r = 0.9993), where A is the absor-
bance at 490 nm, C is the concentration of CIN in μg/
ml in the range of 3 - 100 μg/ml, and r is the correla-
tion coefficient. The molar absorptivity (ε) was 4.2 × 105
l/mol/cm. The limit of detection (LOD) and limit of
quantification (LOQ) were determined according to The
International Conference of Harmonization (ICH)
Table 1 Summary for the optimization of variables
affecting the reaction of CIN with NQS reagent employed
in the development of the proposed spectrophotometric
method
Variable Studied range Optimum
NQS concentration (%, w/v) 0.1 - 0.9 0.5
pH 6 - 10 8.5
Temperature (°C) 25 - 60 25
Time (min) 5 - 35 10
Diluting solvent Differenta Water
Measuring wavelength (nm) 400 - 600 490
a solvents were: methanol, ethanol, isopropanol, acetone, acetonitrile, and 1,4-
dioxane.
Figure 5 Limiting logarithmic plot for molar reactivity of CIN
with NQS. C and A are the concentration and absorbance,
respectively. For generating the first line (♦), [NQS]: 1.9 × 10-3; [CIN]:
7.6 × 10-6 - 2.5 × 10-4 M. For generating the second line (●), [NQS]:
1.9 × 10-3 - 9.6 × 10-3 M; [CIN]: 1 × 10-4M.
  CIN 















Figure 6 Scheme for the reaction pathway of CIN with NQS.
Figure 7 Linear plot for log C versus log K for the kinetic
reaction of CIN with NQS. C is the CIN concentration (7.6 × 10-6 -
2.5 × 10-4 M) and K is the reaction rate (second-1).
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guidelines for validation of analytical procedures [31].
The following formula was used: LOD or LOQ = ×SDa/
b, where × = 3.3 for LOD and 10 for LOQ, SDa is the
standard deviation of the intercept, and b is the slope.
The LOD and LOQ were found to be 1.9 and 5.7 μg/ml,
respectively. The parameters for the analytical perfor-
mance of the proposed method are summarized in
Table 2.
Precision
The intra-assay precision of the proposed method was
determined on samples of drug solutions at varying con-
centration levels (Table 3) by analyzing 5 replicates of
each sample as a batch in a single assay run. The inter-
assay precision was determined by analyzing the same
samples as duplicates in three consecutive days. The
relative standard deviations (RSD) did not exceed 0.78%
(Table 3) proving the high precision of the proposed
method for the routine application in the analysis of
CIN in quality control laboratories.
Accuracy and Interference Liabilities
The accuracy of the proposed method was evaluated by
the recovery studies for added concentrations. The
recovery values were 98.60 - 99.96 ± 0.01 - 0.21% (Table
4), indicating the accuracy of the proposed method.
Before proceeding with the analysis of CIN in its dosage
forms, interference liabilities were carried out to explore
the effect of inactive ingredients that might be added
during formulation [32]. Samples were prepared by mix-
ing known amount (30 mg) of CIN with 50 mg of pre-
gelatinized starch, 50 mg of microcrystalline cellulose,
10 mg of povidone, 10 mg crospovidone, 10 mg of col-
loidal silicon dioxide and magnesium stearate. These
laboratory-prepared samples were analyzed by the pro-
posed method applying the general recommended pro-
cedure. The average recovery value was of 100.57 ±
1.51% (Table 5). These data confirmed the absence of
interference from any of the inactive ingredients with
the determination of CIN by the proposed method.
Robustness and Ruggedness
Robustness was examined by evaluating the influence of
small variation in the method variables on its analytical
performance. In these experiments, one parameter was
changed whereas the others were kept unchanged, and
the recovery percentage was calculated each time. It was
found that small variation in the method variables did
not significantly affect the procedures; recovery values
were 98.87 - 101.41 ± 0.26 - 0.86% (Table 6). This indi-
cated the reliability of the proposed method during its
routine application for the analysis of CIN.
Ruggedness was also tested by applying the proposed
methods to the assay of CIN using the same operational
conditions but using two different instruments at two
different laboratories and different elapsed time. Results
obtained from lab-to-lab and day-to-day variations were
reproducible, as the relative standard deviations (RSD)
did not exceed 2%.
Table 2 Parameters for the performance of the proposed
spectrophotometric method for determination of CIN
Parameter Value
Measurement wavelength (nm) 490
Linear range (μg/ml) 3 - 100
Intercept 0.0092
Standard deviation of the intercept 0.0051
Slope 0.0090
Standard deviation of the slope 0.0001
Correlation coefficient (r) 0.9993
Limit of detection, LOD (μg/ml) 1.9
Limit of quantification, LOQ (μg/ml) 5.7
Molar absorptivity, ε (l/mol/cm) 4.2 × 105
Table 3 Precision of the proposed assay at different CIN
concentrations
Concentration (μg/ml) Relative standard deviation














1 10 9.86 98.60 ± 0.12
2 20 19.85 99.25 ± 0.21
3 40 39.95 99.88 ± 0.12
4 80 79.93 99.91 ± 0.01
5 100 99.96 99.96 ± 0.04
a Values are mean of three determinations.
Table 5 Analysis of CIN in presence of the excipients that
are present in its tablets by the proposed method
Excipient Recovery (% ± SD)a
Pregelatinized starch (50)b 102.09 ± 0.26
Microcrystalline cellulose (50) 102.0 ± 0.57
Povidone (10) 99.28 ± 0.27
Cross povidone (10) 99.25 ± 0.25
Colloidal silicon dioxide (10) 98.34 ± 0.26
Magnesium stearate (10) 101.16 ± 0.95
Average ± SD 100.57 ± 1.51
a Values are mean of three determinations.
b Figures in parenthesis are the amounts in mg added per 30 mg of CIN.
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Application of the Proposed Method to Analysis of CIN in
Tablets
It is evident from the above-mentioned results that the
proposed method gave satisfactory results with CIN in
bulk. Thus its pharmaceutical dosage forms (Sensipar®
and Mimpara® tablets) were subjected to the analysis of
their CIN contents by the proposed and reference
method. Since there was neither official method nor
reported spectrophotometric method for the quantitative
determination of CIN in its tablets, a pre-validated chro-
matographic method developed in our laboratory was
used as a reference method [Khalil NY, Wani TA,
Darwish IA: An ICH-validated high-performance liquid
chromatographic method with fluorescence detection
for determination of cinacalcet hydrochloride in tablets
and plasma, unpublished]. The label claim percentages
were 102.23 ± 1.27 and 100.80 ± 1.60% for Sensipar®
and Mimpara® tablets, respectively (Table 7). This result
was compared with that obtained from the reference
method by statistical analysis with respect to the accu-
racy (by t-test) and precision (by F-test). No significant
differences were found between the calculated and theo-
retical values of t- and F-tests at 95% confidence level
proving similar accuracy and precision in the determina-
tion of CIN by both methods.
Conclusions
The present study described, for the first time, the suc-
cessful evaluation of NQS as an analytical reagent in the
development of simple and rapid spectrophotometric
method for the accurate determination of CIN in its
dosage forms. The method described herein has many
advantages: it does not need expensive sophisticated
apparatus, it is simple and rapid, and it has high sensi-
tivity. The proposed method used inexpensive reagents
with excellent shelf life, and is available in any analytical
laboratory. Therefore, the method is practical and valu-
able for its routine application in quality control labora-
tories for analysis of CIN.
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